chronic myelogenous leukemia

(redirected from Chronic myelogenous leukaemia)

chronic myelocytic leukemia

a heterogeneous group of myeloproliferative disorders that may evolve into acute leukemia in late stages (that is, blast crisis.)

chronic myelogenous leukemia

Leukemia characterized by abnormally high levels of granulocytes in the blood and bone marrow and by the presence in most of these cells of an abnormal chromosome (the Philadelphia chromosome), occurring primarily in older adults and typically having a slow progression with early symptoms including fatigue and an enlarged spleen. Also called chronic granulocytic leukemia, chronic myelocytic leukemia, chronic myeloid leukemia.

chronic myelogenous leukemia

Myeloproliferative neoplasm characterized by the unregulated and excessive production of cells of the myelocytic maturation series and presence of the BCR/ABL 1 mutation. Compare acute lymphocytic leukemia, chronic lymphocytic leukemia, leukemoid reaction. See also acute myelocytic leukemia, chronic myelocytic leukemia, leukocytosis.

chron·ic my·e·lo·cyt·ic leu·ke·mi·a

(kron'ik mī'ĕ-lō-sit'ik lū-kē'mē-ă)
A heterogeneous group of myeloproliferative disorders that may evolve into acute leukemia in late stages (i.e., blast crisis). Slow onset, usually in olderadults.
Synonym(s): chronic granulocytic leukemia, chronic myelogenous leukemia, chronic myeloid leukemia.

Chronic myelogenous leukemia (CML)

Also called chronic myelocytic leukemia, malignant disorder that involves abnormal accumulation of white cells in the marrow and bloodstream.
References in periodicals archive ?
She will now head Avillion as it arranges to progress its first collaborative development agreement with Pfizer to carry out a global phase III clinical trial evaluating Bosulif (bosutinib) as a first-line treatment in chronic myelogenous leukaemia.
Healthcare company Pfizer Inc (NYSE:PFE) announced on Tuesday that the US Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukaemia (CML) with resistance, or intolerance to prior therapy.
Summary: Eight-year-old Emirati, Maha Abdulla is the only known surviving patient in the UAE suffering from chronic myelogenous leukaemia (CML) which is an uncommon type of cancer of the blood cells.
It is also investigated for additional indications, such as myelodysplastic syndrome (MDS) and chronic myelogenous leukaemia (CML).
The Love Story star was diagnosed with chronic myelogenous leukaemia less than a month ago and today said he was being given a treatment which seems to be working.

Full browser ?